The creation of a tissue array begins with careful selection of donor tissue samples, which are typically formalin-fixed and paraffin-embedded (FFPE) specimens stored in pathology archives. Each donor block contains valuable information about a patient’s clinical history, diagnosis, and disease characteristics. Researchers identify regions of interest within these blocks using standard histopathological examination. Once the target areas are selected, a tissue microarrayer, an instrument designed specifically for this purpose, is used to extract small cores, usually 0.6 to 2.0 mm in diameter, from the designated regions. These cores are then precisely embedded into a recipient paraffin block at predetermined coordinates to form the array. The arrangement of samples in a tissue array can include hundreds of cores representing various tissue types, disease stages, or experimental groups. Once constructed, the recipient block is sectioned using a microtome to produce multiple identical slides that can be stained and analyzed in a consistent manner. This uniformity is one of the major advantages of the tissue array method, as it allows for standardized comparison of multiple samples using identical staining conditions and reagents, minimizing variability that could arise from individual slide preparation.

Tissue arrays have become a cornerstone in cancer research due to their ability to facilitate large-scale validation of molecular biomarkers. In oncology, researchers are often interested in studying the expression patterns of specific genes or proteins across a wide spectrum of tumor samples. For example, immunohistochemistry (IHC) staining on a tissue array can reveal differences in protein expression between malignant and benign tissues or among tumors of different grades and stages. This makes tissue arrays particularly useful in identifying diagnostic markers, prognostic indicators, and potential therapeutic targets. Because the same experimental protocol can be applied to hundreds of specimens on one slide, tissue arrays provide a cost-effective and time-saving platform for high-throughput screening of potential biomarkers. Furthermore, the integration of hepatocellular carcinoma (HCC) tissue microarray array data with clinical information allows researchers to correlate molecular findings with patient outcomes, offering insights into disease progression, treatment response, and survival rates. This correlation has profound implications for precision medicine, where treatment decisions are tailored to the individual molecular profile of a patient’s tumor.

In addition to cancer research, tissue arrays are increasingly used in studying a wide range of diseases such as cardiovascular disorders, neurological conditions, infectious diseases, and inflammatory processes. By including normal, diseased, and treated tissue samples within a single array, scientists can investigate pathological mechanisms and therapeutic effects in a controlled, comparative framework. For example, in neuroscience, tissue arrays have been utilized to explore protein expression in brain tissues affected by Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative conditions. Similarly, in immunology, arrays help researchers study immune responses in tissues infected by viruses or bacteria, allowing for simultaneous assessment of cytokine expression or immune cell infiltration. The versatility of tissue arrays extends to pharmacological research as well, where drug efficacy and toxicity can be evaluated across different tissue types using the same experimental setup. This application is particularly valuable in preclinical testing, where rapid and cost-effective screening of candidate drugs is essential.

One of the key strengths of tissue arrays lies in their compatibility with multiple molecular analysis techniques beyond traditional histopathology. In addition to immunohistochemistry, tissue arrays can be used for in situ hybridization (ISH), fluorescence in situ hybridization (FISH), and even next-generation sequencing (NGS)-based assays, depending on the preservation quality of nucleic acids within the paraffin-embedded samples. This flexibility allows researchers to assess not only protein expression but also DNA mutations, RNA transcripts, and epigenetic modifications in a spatially preserved tissue context. For example, FISH assays performed on tissue arrays can identify chromosomal aberrations, gene amplifications, or translocations across hundreds of samples in a single experiment. Similarly, RNA in situ hybridization enables visualization of gene expression patterns within tissue architecture, providing valuable information about the localization of specific transcripts. The integration of these molecular techniques with tissue array platforms supports comprehensive, multidimensional analyses that bridge histopathological and genomic data, enhancing our understanding of disease biology.